Page last updated: 2024-10-21

isopentenyl pyrophosphate and Lymphoma, B-Cell

isopentenyl pyrophosphate has been researched along with Lymphoma, B-Cell in 2 studies

isopentenyl pyrophosphate: substrate for isopentenyl pyrophosphate isomerase; RN given refers to unlabeled cpd; a nonpeptide mycobacterial antigen that stimulates gamma delta T cells
isopentenyl diphosphate : A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent.

Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.

Research Excerpts

ExcerptRelevanceReference
"Isopentenyl pyrophosphate (IPP) was previously proposed as the main Ag responsible for Vgamma9Vdelta2 T cell activation by cancer cells."1.35Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen. ( Champagne, E; Collet, X; Davrinche, C; Martin, H; Martinez, LO; Mookerjee-Basu, J; Périgaud, C; Perret, B; Peyrottes, S; Pont, F; Rolland, C; Vantourout, P, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vantourout, P1
Mookerjee-Basu, J1
Rolland, C1
Pont, F1
Martin, H1
Davrinche, C1
Martinez, LO1
Perret, B1
Collet, X1
Périgaud, C1
Peyrottes, S1
Champagne, E1
Wang, P1
Malkovsky, M1

Other Studies

2 other studies available for isopentenyl pyrophosphate and Lymphoma, B-Cell

ArticleYear
Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen.
    Journal of immunology (Baltimore, Md. : 1950), 2009, Sep-15, Volume: 183, Issue:6

    Topics: Adenosine Monophosphate; Adenosine Triphosphate; Antigen-Presenting Cells; Cell Line, Tumor; Cells,

2009
Different roles of the CD2 and LFA-1 T-cell co-receptors for regulating cytotoxic, proliferative, and cytokine responses of human V gamma 9/V delta 2 T cells.
    Molecular medicine (Cambridge, Mass.), 2000, Volume: 6, Issue:3

    Topics: Antigen-Presenting Cells; CD2 Antigens; Clone Cells; Cytotoxicity, Immunologic; Hemiterpenes; Humans

2000